BJL
NVO

Brighton Jones LLC’s Novo Nordisk NVO Stock Holding History

Brighton Jones LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Buy
7,245
+1,088
+18% +$46.7K 0.01% 974
2026
Q1 		$226K Buy
+6,157
New +$292K 0.01% 1040
2025
Q4 		– Sell
-13,976
Closed -$776K – 654
2025
Q3 		$776K Sell
13,976
-130
-0.9% -$7.61K 0.02% 475
2025
Q2 		$974K Buy
14,106
+343
+2% +$23.3K 0.03% 332
2025
Q1 		$956K Sell
13,763
-374
-3% -$30.9K 0.03% 272
2024
Q4 		$1.22M Sell
14,137
-1,039
-7% -$112K 0.04% 227
2024
Q3 		$1.81M Buy
15,176
+606
+4% +$80.8K 0.07% 143
2024
Q2 		$2.08M Buy
14,570
+5,625
+63% +$745K 0.07% 148
2024
Q1 		$1.15M Buy
8,945
+1,134
+15% +$135K 0.04% 204
2023
Q4 		$808K Buy
7,811
+501
+7% +$49.5K 0.03% 236
2023
Q3 		$665K Buy
7,310
+1,500
+26% +$132K 0.03% 237
2023
Q2 		$470K Buy
5,810
+508
+10% +$41.5K 0.02% 306
2023
Q1 		$422K Buy
5,302
+66
+1% +$4.68K 0.02% 316
2022
Q4 		$354K Sell
5,236
-268
-5% -$15.7K 0.02% 304
2022
Q3 		$274K Buy
5,504
+848
+18% +$45.4K 0.02% 353
2022
Q2 		$259K Buy
4,656
+68
+1% +$3.77K 0.02% 360
2022
Q1 		$255K Buy
4,588
+74
+2% +$3.8K 0.01% 413
2021
Q4 		$253K Buy
+4,514
New +$245K 0.01% 425
2018
Q4 		– Sell
-10,060
Closed -$237K – 280
2018
Q3 		$237K Buy
+10,060
New +$246K 0.03% 238

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Brighton Jones LLC's NVO Position: Q2 2026 in Review

Brighton Jones LLC increased its Novo Nordisk (NVO) stake by 18% in Q2 2026, buying an estimated $46.7K and bringing the position to 7,245 shares worth $347K. The position accounts for 0.01% of the portfolio, ranked #974.

Brighton Jones LLC first reported a position in NVO in Q3 2018 and has held it in 19 quarters since. The position peaked at $2.08M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Brighton Jones LLC held 7,245 shares of Novo Nordisk worth $347K as of Q2 2026.
  • Brighton Jones LLC bought 1,088 Novo Nordisk shares in Q2 2026, an estimated $46.7K.
  • Novo Nordisk made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #974 holding.
  • Brighton Jones LLC first reported a position in Novo Nordisk in Q3 2018 and has held it in 19 quarters since.
  • Brighton Jones LLC's Novo Nordisk position peaked at $2.08M in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.